Fig. 3.
Fig. 3. RNAse protection analysis of the GMRβ chain using total RNA from hematopoietic cell lines (TF-1), primary myeloid cells (purified neutrophils, CD34+ cells, and mononuclear cells from normal bone marrow), and leukemic blasts from patients with AML. The full-length probe of 248 bp protected a fragment of 191 bp from nucleotides 1429 to 1620 of the published βC chain sequence17 and 64 bp for the βIT chain.

RNAse protection analysis of the GMRβ chain using total RNA from hematopoietic cell lines (TF-1), primary myeloid cells (purified neutrophils, CD34+ cells, and mononuclear cells from normal bone marrow), and leukemic blasts from patients with AML. The full-length probe of 248 bp protected a fragment of 191 bp from nucleotides 1429 to 1620 of the published βC chain sequence17 and 64 bp for the βIT chain.

Close Modal

or Create an Account

Close Modal
Close Modal